Examination of Fig 4 reveals that activation of the MYC proto-oncogene is significantly associated with the downregulated DEGs identified for all tumor subtypes in this study (Fig 4B) as well as the upregulated DEGs for fibrosarcomas and peripheral nerve sheath tumors (Fig 4A). This evidence concerns the gene MYC and fibrosarcoma.